Close Menu

University of Florida

Erada Technology Alliance said the Global Health Innovative Technology Fund grant facilitates production, testing, and validation trials for the rapid test for malaria.

DiaCarta scientists will partner with the University of Florida Health Cancer Center to analyze blood samples from up to 500 cancer patients undergoing radiotherapy.

By dropping the cutoff value in urine immunoassay testing to 20 from 100, the researchers reduced the false-negative rate to 2 percent from 47 percent.